Narrow Results Clear All
- Communication Improvement 1
- Culture of Safety 1
- Education and Training 1
- Error Reporting and Analysis 2
- Human Factors Engineering 3
- Quality Improvement Strategies 2
- Technologic Approaches 1
Search results for "Chemotherapeutic Agents"
Journal Article > Study
Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.
Gilbar P, Chambers CR, Larizza M. J Oncol Pharm Pract. 2015;21:10-18.
The chemotherapy drug vincristine almost always causes fatal toxicity if it is incorrectly administered intrathecally (via spinal injection) rather than intravenously. This hazard is well publicized, but accidental administration of intrathecal vincristine continues to occur. This survey of oncology pharmacists found that many pharmacies still lack appropriate safeguards to prevent such errors.
ISMP Medication Safety Alert! Acute Care Edition. November 14, 2013;18:1-4.
This newsletter article reports on concerns associated with chemotherapy preparations due to variations in concentration and recommends standardized preparation processes to address such risks.
Toronto, ON, Canada: Institute for Safe Medication Practices Canada. April 30, 2007.
External Inquiry into the adverse incident that occurred at Queen's Medical Centre, Nottingham, 4th January 2001.
Toft B. London, England: Department of Health; 2001.
This UK Department of Health report details a series of errors that led to the death of a young man due to wrong route administration of the chemotherapy drug vincristine. The fatality occurred as a result of a socio-technical systems failure at the hospital where he received the injection. The report makes 48 recommendations to help minimize the likelihood of this mistake.
Information Exchange System Alert. Geneva, Switzerland: World Health Organization; July 18, 2007.
This international announcement provides guidance on the safe administration of the chemotherapeutic agent vincristine.